Vacuum-assisted Biopsy Devices Market Size, Share, Growth, and Industry Analysis by Type (9-12G, <9G, >12G) by Application (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

VACUUM ASSISTED BIOPSY DEVICES MARKET REPORT OVERVIEW

The global vacuum-assisted biopsy devices market size was USD 0.07939 billion in 2025 and is projected to touch USD 0.14436 billion by 2034, exhibiting a CAGR of 6.91% during the forecast period.

Vacuum-assisted biopsy devices are specialized tools used in medical procedures to obtain tissue samples from the body for diagnostic purposes, particularly for cancer detection.  The procedure is done to determine the presence or extent of a disease, including inflammatory and cancerous conditions. The prevalence of chronic diseases is escalating the growth of breast biopsy devices market. Vacuum-assisted biopsy devices allow health care professionals to obtain greater tissue samples associated to traditional methods, enhancing diagnostic exactness while dropping patient uneasiness. As tailored treatment schedules gain traction, the capacity to acquire precise and adequate tissue samples for molecular analysis becomes progressively important. Vacuum-assisted biopsy devices are suitable for these purposes, as they allow the collection of large tissue samples, which is vital for detailed molecular profiling. Vacuum-assisted biopsy devices are progressively used for prostate cancer diagnosis due to their capacity to deliver superior tissue samples with negligible uneasiness to the patient. These devices enable the early detection of prostate cancer, letting for appropriate intervention and treatment.

Participants are fixing their efforts on encouraging R&D. Technological development are supporting the regional market growth. Companies need to stay updated with varying market trends and develop products that meet rising consumer needs. Companies coming up with advanced technological solutions for firming their positions.  

COVID-19 IMPACT:  

Pandemic Affected The Market Due To Unexpected Disruptions In The Sector

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic had a significant negative impact on the market. Hospitals line up emergency care, while patients deferred or evaded medical visits due to contagion concerns. Supply chain disturbances further impacted the accessibility of significant components, deferring product manufacturing and delivery. Clinical training plans and device installations were also paused, slowing market penetration and development.

LATEST TRENDS

Use Of Innovative Products To Boost The Market Growth

Technological upgrading and improvement will further enhance the presentation of the product, allowing it to obtain a varied range of requests in the market. Technological advancement will improve performance and propel the market growth. Technological development with high demand is increasingly setting a force to increase the productivity. Some players focus on product improvement to meet consumer requirements and likings. Constant upgrading in manufacturing of products is anticipated to stimulate product demand.

•   
•   
  

  Request a Free sample to learn more about this report

    

VACUUM ASSISTED BIOPSY DEVICES MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into 9-12G, <9G, >12G

• 9-12G: This is the leading sector, extensively used in clinical settings for breast, lung, and soft tissue biopsies. These devices offer a stability between tissue capacity and patient ease, letting sufficient sample size for histological analysis while diminishing invasiveness.

• <9G: Needles greater than 9G are used when bigger tissue samples are vital, such as for more complex or suspicious lesions. These are typically employed in high-risk or repeat biopsy cases. While they offer enhanced diagnostic confidence, they may increase patient discomfort, limiting use to specialized settings.

• >12G: Smaller than 12G, these needles are less invasive and are used when tissue preservation and patient comfort are prioritized, especially for superficial or small lesions.

By Application Analysis

According to application, the market can be segmented into Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers

• Hospitals: Hospitals offer access to advanced imaging systems, trained personnel, and support for a wide-ranging variety of biopsy events. vacuum-assisted biopsy devices are mostly used in oncology, radiology, and surgical departments for precise diagnosis and treatment development. Multi-specialty hospitals mainly favour vacuum-assisted methods for their output and diagnostic reliability.

• Academic and Research Institutes: Academic hospitals and research centres often join in pilot studies and trials connecting novel biopsy devices or protocols. Though lesser in volume associated to hospitals, this sector plays a vibrant role in technological development and product response for producers.

• Diagnostic and Imaging Centers: These amenities desire portable, cost-efficient vacuum-assisted biopsy devices that are well-suited with in-house imagery equipment. Their request lies in quicker patient wait times, lesser costs, and high output, particularly for routine breast cancer screenings and targeted soft tissue biopsies.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Incidence Of Breast Cancer To Boost The Market Growth

The growing occurrence of breast cancer across the world is driving the demand for vacuum-assisted biopsy devices. These devices are extensively used for the diagnosis and staging of breast cancer, leading to an augmented implementation in the market. Initial and exact diagnosis is vital to improving survival rates, and vacuum-assisted biopsy devices play a vital role in this procedure. These devices let for slightly hostile, image-guided tissue sample, often used to estimate non-palpable scratches or microcalcifications noticed during mammography.

Technological Advancement and Innovation To Upsurge The Market

Technological advancements and innovation activate unique revenue augmenting opportunity which will upsurge the vacuum-assisted biopsy devices market growth. Growing investment in research and development activities and growing awareness about benefits are expected to deliver profitable opportunities for the market. Technological developments in biopsy techniques, such as vacuum-assisted biopsy, have better-quality the exactness and productivity of the process. This has led higher demand for vacuum-assisted biopsy devices, as they offer improved sampling and reduced procedure time associated to traditional biopsy procedures.

Restraining Factor

Limited Access to Imaging Infrastructure and Skilled Personnel To Hamper The Market Growth

Vacuum-assisted biopsy often needs immediate ultrasound, stereotactic X-ray, or MRI direction. In resource-limited settings, absence of access to progressive imaging sensory system or expert radiologists can encouragingly deter implementation. Furthermore, the steep learning curve related with vacuum-assisted biopsy methods makes training and documentation crucial. A lack of qualified radio therapist and interventional technologists further restricts the accessibility of these events in several areas. Without proper training and technology, the danger of inaccurate sampling or problems surges, reducing clinical confidence in the technique.

Rising Demand for Outpatient and Ambulatory Procedures To Create Opportunity in the Market

Opportunity

The global healthcare inclination toward outpatient care, same-day procedures, and negligibly invasive diagnostics line up well with the vacuum-assisted biopsy devices market. Vacuum-assisted biopsies are progressively being executed in ambulatory surgical centres, diagnostic labs, and outpatient imaging centres.

This setting demands portable, cost-effective, and easy-to-use biopsy systems, opening the door for producers to progress rationalized, clinic-friendly solutions that do not need hospital-level infrastructure.

Procedural Complexity and Learning Curve Could Be a Major Challenge

Challenge

Simpler biopsy methods such as fine-needle goal or core-needle biopsy, vacuum-assisted procedures need exact image direction, precise device arrangement, and exact needle control to certify safe and operative tissue sampling. The procedure can be technically demanding, mainly when directing small or deep scratches under ultrasound, MRI, or stereotactic direction.

Clinicians must experience focused training to master the technique, interpret actual imagery appropriately, and achieve device-specific features. Inexperienced workers may face complications with insertion angles, tissue acquisition, or certifying patient comfort, leading to possible diagnostic faults or repeat procedures.

•   
•   
  Request a Free sample to learn more about this report

    

VACUUM ASSISTED BIOPSY DEVICES MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East and Africa.

• North America

North America embraces the major share of the vacuum-assisted biopsy devices market, determined by high cancer occurrence, well-established screening plans, and progressive healthcare infrastructure. The United States leads in implementation due to sturdy reimbursement strategies, extensive accessibility of imaging equipment, and constant technological innovation which motivate the vacuum-assisted biopsy devices market share.

• Asia

The Asia-Pacific region is the fastest-growing market, determined by growing cancer occurrence, expanding healthcare infrastructure, and growing public awareness. Urban hospitals and private diagnostic centres are implementing ultrasound and MRI-guided biopsy systems, mainly for breast and lung cancer analysis.

• Europe

Europe region aids from high awareness and initial discovery efforts, though stringent guidelines can postpone the introduction of innovative devices. Stereotactic and MRI-guided vacuum biopsies are well-integrated into breast cancer diagnostics. The region benefits from sturdy reimbursement policies and the accessibility of progressive imaging technologies.

KEY INDUSTRY PLAYERS

Key Players Focus On Partnerships To Gain Competitive Advantage

The key players are dynamically contributing in strategic events that are aimed at maintaining strong market position and increasing market share by merger, partnerships and others. Key players are motivated to introduce new innovative products. They are spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market. The market changes are dynamic such as market expansion, partnership and merger. The collective efforts of these major players expressively impact the competitive landscape and future path of the market.

List Of Market Players Profiled

• Hologic (U.S.)
• BD (U.S.)
• Mammotome (Ohio)

INDUSTRIAL DEVELOPMENT

October 2020:   Hologic announced the launch of the Trident HD Specimen Radiography System, which is designed to enhance workflow and improve efficiency in breast-conserving surgeries and vacuum-assisted biopsies.

REPORT COVERAGE

The report provides scrutiny and information according to market sectors. Business overview, financial overview, product portfolio, new project launch, recent development enquiry are the factors included in the profile. The report incorporates completely examined and appraised evidence of the noticeable players and their position in the market by methods for various descriptive tools. The report covers national and regional level market size and forecast. The report gives businesses the facility to research new prospect in many areas. The report shows to be an operational tool that players can use to gain a competitive superiority over their opponents and ensure lasting achievement in the market.